Patents by Inventor Chuanwen YANG

Chuanwen YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND
    Publication number: 20240239746
    Abstract: A preparation method for a pyrrole amide compound, as shown in formula (II). The preparation method includes: reacting a compound of formula (III) with a compound of formula (IV) in the presence of a palladium catalyst and a ligand, wherein X is Br or I; R is H, D, F, Cl, Br, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl or C1-4 haloalkoxy; and PG1 is benzyl or substituted benzyl.
    Type: Application
    Filed: April 19, 2022
    Publication date: July 18, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancheng WANG, Yingxun ZHANG, Chuanwen YANG, Qiao ZONG, Facheng MA, Xiaohong DING, Xiaojun WANG
  • Fluorine-substituted indazole compounds and uses thereof
    Patent number: 11242335
    Abstract: A class of fluorine-substituted indazole compounds and uses thereof having the general formula depicted below in which C1 is where is the bond through which C1 is attached to L, and C2 is where is the bond through which C2 is attached to indazole, and pharmaceutical compositions containing these compounds. The compounds and pharmaceutical compositions of the invention can be used as soluble guanylate cyclase simulators.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: February 8, 2022
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Yinglin Zuo, Xiaojun Wang, Chuanwen Yang, Jiancheng Wang, Shengtian Cao, Fangyuan Wu, Yingjun Zhang, Siegfried Goldmann
  • PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF
    Publication number: 20210206760
    Abstract: A phenyl-substituted dihydronaphthyridine compound and use thereof, and further relates to a pharmaceutical composition including the compound. According to the present invention, the compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.
    Type: Application
    Filed: May 20, 2019
    Publication date: July 8, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Chuanwen YANG, Xiaojun WANG, Yinglin ZUO, Yingjun ZHANG, Jiancheng WANG, Hui WANG, Bo CHI
  • FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF
    Publication number: 20210101882
    Abstract: A class of fluorine-substituted indazole compounds and uses thereof, further to pharmaceutical compositions containing these compounds. The compounds and pharmaceutical compositions of the invention can be used as soluble guanylate cyclase simulators.
    Type: Application
    Filed: April 10, 2018
    Publication date: April 8, 2021
    Applicants: SUNSHINE LAKE PHARMA CO., LTD., NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Yinglin ZUO, Xiaojun WANG, Chuanwen YANG, Jiancheng WANG, Shengtian CAO, Fangyuan WU, Yingjun ZHANG, Siegfried GOLDMANN
  • Cathepsin K inhibitors and application thereof
    Patent number: 10494364
    Abstract: The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: December 3, 2019
    Assignees: SUNSHIN LAKE PHARMA CO., LTD, NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Xiaojun Wang, Pingjian Zhou, Chuanwen Yang, Changwei Huang, Shaohui Xiong, Yingjun Zhang, Jiancun Zhang
  • CATHEPSIN K INHIBITORS AND APPLICATION THEREOF
    Publication number: 20180230138
    Abstract: The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.
    Type: Application
    Filed: August 26, 2016
    Publication date: August 16, 2018
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Xiaojun WANG, Pingjian ZHOU, Chuanwen YANG, Changwei HUANG, Shaohui XIONG, Yingjun ZHANG, Jiancun ZHANG